COVID-19 rapid test TRFIA
IgGIgMSARS-COV-2

COVID-19 rapid test
COVID-19 rapid test
COVID-19 rapid test
COVID-19 rapid test
COVID-19 rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
IgG, IgM
Micro-organism
SARS-COV-2
Sample type
serum, plasma, whole blood
Analysis mode
lateral flow

Description

IgM is the first antibody to appear in the acute infection stage caused by pathogens such as SARS CoV-2, and can normally be detected 3 days after the onset of symptoms, IgG is produced in the middle or later stage of the infection but provides long-term protection. In the latest 7th edition of the Diagnosis and Treatment Guideline on the Novel Coronavirus Disease (COVID-19), the SARS-CoV 2 IgG/IgM test is recommended as an aid in the diagnosis of the COVID-19. SARS-CoV-2 IgG/IgM Kit is used for rapid and accurate screening of the COVID-19, which helps identify suspected patients and reduce false negative rate. Rapid detection of recent SARS-CoV-2 infection ● In ONLY 12 minutes ● ONE-STEP operation ● Single cartridge, NO additional buffers ● TRFIA Europium particles displays Clear and Bright results ● Dual capturing antigens (S and N) enhanced sensitivity ● Important complement to PCR detection in COVID-19 diagnosis

VIDEO

Catalogs

FIA GO
FIA GO
2 Pages
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.